Roivant Sciences ROIV
NASDAQ ROIV
$41.15 +0.48 (+1.18%)
As of: Nov 10, 2026 · 3:26 PM EST

Roivant Sciences (ROIV) EV to EBITDA (2023 - 2024)

Updated

Roivant Sciences' (ROIV) EV to EBITDA stood at 0.78 in fiscal Q2 2025 (quarter ended Sep 30, 2024), up 40.1% from the prior quarter.

Analysis

Roivant Sciences (ROIV) EV to EBITDA (2023 - 2024) Analysis & Trends

On a TTM basis, Roivant Sciences' EV to EBITDA came in at -3.42 as of Sep 30, 2024; for FY2024 (ended Mar 31, 2024), it came in at 0.55.

  • Per Business Quant, the preceding three fiscal quarters came in at 0.56 (Q1 2025), 0.56 (Q4 2024) and 0.60 (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Roivant Sciences 28.91 Bn 11.86 Bn 1.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 0.78
Jun 30, 2024 0.56
Mar 31, 2024 0.56
Dec 31, 2023 0.60
API Access

Roivant Sciences EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ROIV&period=max&api_key=YOUR_API_KEY